Martin Christopher Nathan bought EWTX
November 19, 2025 · Form 4 insider transaction
Martin Christopher Nathan bought 45,150 shares of Edgewise Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,150
Price
$0.00
Total value
N/A
InsiderMartin Christopher Nathan
RoleDirector
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 19, 2025
Filing dateNovember 24, 2025
Shares owned after45,150
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/36th of the shares subject to the option vest each month beginning on December 19, 2025, subject to the Reporting Person continuing as a service provider through each vest date.